Weighted Average Number of Shares Outstanding, Basic of CANNAPHARMARX, INC. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CANNAPHARMARX, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • CANNAPHARMARX, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 662,501,405, unchanged year-over-year.
  • CANNAPHARMARX, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 211,044,357, a 183% increase from 2021.
  • CANNAPHARMARX, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 74,686,563, a 84% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CANNAPHARMARX, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 662,501,405 0 0% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 662,501,405 +4,521,193 +0.69% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 662,501,405 +311,981,731 +89% 01 Jan 2025 31 Mar 2025 10-Q 16 May 2025 2025 Q1
Q3 2024 662,501,405 +367,405,402 +125% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 657,980,212 +358,324,148 +120% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 350,519,674 +57,630,060 +20% 01 Jan 2024 31 Mar 2024 10-Q 16 May 2025 2025 Q1
Q3 2023 295,096,003 +53,997,966 +22% 01 Jul 2023 30 Sep 2023 10-Q 17 Nov 2023 2023 Q3
Q2 2023 299,656,064 +99,820,798 +50% 01 Apr 2023 30 Jun 2023 10-Q 13 Oct 2023 2023 Q2
Q1 2023 292,889,614 +143,674,018 +96% 01 Jan 2023 31 Mar 2023 10-Q 25 Jun 2024 2024 Q1
Q4 2022 211,044,357 +136,357,794 +183% 01 Oct 2022 31 Dec 2022 10-K 01 Sep 2023 2022 FY
Q3 2022 241,098,037 +156,682,764 +186% 01 Jul 2022 30 Sep 2022 10-Q 17 Nov 2023 2023 Q3
Q2 2022 199,835,266 +142,600,253 +249% 01 Apr 2022 30 Jun 2022 10-Q 13 Oct 2023 2023 Q2
Q1 2022 149,215,596 +101,172,531 +211% 01 Jan 2022 31 Mar 2022 10-Q 22 Sep 2023 2023 Q1
Q4 2021 74,686,563 01 Oct 2021 31 Dec 2021 10-K 01 Sep 2023 2022 FY
Q3 2021 84,415,273 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 57,235,013 01 Apr 2021 30 Jun 2021 10-Q 22 Aug 2022 2022 Q2
Q1 2021 48,043,065 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1

CANNAPHARMARX, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 211,044,357 +136,357,794 +183% 01 Jan 2022 31 Dec 2022 10-K 01 Sep 2023 2022 FY
2021 74,686,563 +33,986,612 +84% 01 Jan 2021 31 Dec 2021 10-K 01 Sep 2023 2022 FY
2020 40,699,951 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.